Skip to main content
OpenTrials

Clinical trial condition

Carbohydrate Metabolism, Inborn Errors

Explore clinical trials studying Carbohydrate Metabolism, Inborn Errors. Study availability and eligibility vary by location and protocol.

544 public trials 96 recruiting studies
Refine in advanced search Browse all conditions

Carbohydrate Metabolism, Inborn Errors trial results

Completed

Prospective Clinical Assessment Study in Children With Achondroplasia (ACH)

NCT04035811

Conditions
Achondroplasia, Bone Diseases, Bone Diseases, Developmental, +16 more
Locations
  • Benioff Children's Hospital Oakland Oakland, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Nemours Alfred I. Dupont Hospital for Children Wilmington, Delaware, United States
  • Johns Hopkins School of Medicine Baltimore, Maryland, United States
View all 32 locations
View Trial Details
Completed

Long-term Evaluation on Height and Weight in Patients With MPS II Who Started Treatment at < 6 Years of Age

NCT02455622

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +17 more
Locations
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Hospital Infantil Dr Robert Reid Cabral Santo Domingo, Dominican Republic
  • Universitätsmedizin der Johannes Gutenberg-Universität Mainz Mainz, Germany
  • Hospital Kuala Lumpur Kuala Lumpur, Malaysia
View Trial Details
Completed

A Study of Adeno-Associated Virus Serotype 8-Mediated Gene Transfer of Glucose-6-Phosphatase in Patients With Glycogen Storage Disease Type Ia (GSDIa)

NCT05139316

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +8 more
Locations
  • Children's Hospital of Orange County Orange, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • University of Connecticut Health Center Farmington, Connecticut, United States
  • Mount Sinai The Bronx, New York, United States
View all 20 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Infigratinib in Children and Adolescents With Achondroplasia

NCT06164951

Conditions
Achondroplasia, Bone Diseases, Bone Diseases, Developmental, +16 more
Locations
  • QED Investigative Site San Francisco, California, United States
  • QED Investigative Site Aurora, Colorado, United States
  • QED Investigative Site Baltimore, Maryland, United States
  • QED Investigative Site Columbia, Missouri, United States
View all 27 locations
View Trial Details
Completed

A Study to Assess the Long-term Safety and Efficacy of ATB200/AT2221 in Adult Subjects With Late-Onset Pompe Disease (LOPD)

NCT04138277

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • University of California, Irvine Irvine, California, United States
  • University of Florida Clinical Research Center Gainesville, Florida, United States
  • Emory Clinic Atlanta, Georgia, United States
View all 60 locations
View Trial Details
Completed

Mucopolysaccharidosis I (MPS I) Registry

NCT00144794

Conditions
Carbohydrate Metabolism, Inborn Errors, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases, +10 more
Locations
  • Phoenix Children's Hospital- Site Number : 840003 Phoenix, Arizona, United States
  • Arkansas Children's Hospital- Site Number : 840109 Little Rock, Arkansas, United States
  • Southern California Permanente Medical Group- Site Number : 840108 Los Angeles, California, United States
  • USC Health Sciences Center Dept of Genetics- Site Number : 840082 Los Angeles, California, United States
View all 141 locations
View Trial Details

Related conditions